Application 208865
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IBUPROFEN | IBUPROFEN | TABLET;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208865-001 | IBUPROFEN | IBUPROFEN | 200MG | TABLET / ORAL | 2017-11-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208865-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2017-11-08 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A208865-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2017-11-08 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A208865-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2017-11-08 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208865-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2017-11-08 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208865-001 | IBUPROFEN | 200MG | TABLET / ORAL | 2017-11-08 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IBUPROFEN | IBUPROFEN | Aurohealth LLC | 3b9773c6-42a0-4834-bef4-4fd60556af48 | 2026-09-11 | Warnings | 208865 ANDA208865 |
| AMAZON BASIC CARE IBUPROFEN | IBUPROFEN | Amazon.com Services LLC | 113dd693-6abe-1a0f-e063-6394a90a167e | 2025-06-06 | Warnings | 208865 ANDA208865 |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | 09bd3935-526d-4ad1-898a-4f0d9499ebb9 | 2024-12-26 | Warnings | 208865 ANDA208865 58602-708 |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | 1100648c-6b9f-49c9-94d0-c40f24fe5c27 | 2022-03-23 | Warnings | 208865 ANDA208865 58602-713 |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | 0ade8ee2-7c74-4b05-925e-d92742fc2b90 | 2022-03-03 | Warnings | 208865 ANDA208865 58602-801 |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | cf6fbf3b-a0f3-4e08-a981-d183fa285758 | 2022-03-03 | Warnings | 208865 ANDA208865 58602-802 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58602-708 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |
| 58602-713 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |
| 58602-801 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |
| 58602-801 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |
| 58602-801 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |
| 58602-802 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |
| 58602-802 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |
| 58602-802 | Ibuprofen | Ibuprofen | Aurohealth LLC | ANDA | Current |